IL6 and central nervous system cancer: Interestingly, our own assessment of the Brain Lower Grade Glioma TCGA PanCancer Atlas dataset (13) highlighted that low expression of TP53I3 and high expression of IL6 and MYC was associated with worse survival in mutant IDH1 tumors but not WT IDH1 (Fig. S16).